In clinical practice, breast erythema is often linked to breast inflammatory diseases. The case of this study is a 44-year-old female, who went to the hospital due to diffuse erythema with swelling on the right breast for four weeks. She was initially diagnosed with stage III breast cancer and received a right-side radical mastectomy. When she was admitted for chemotherapy three weeks after the sur-gery, she was found to have leukocytosis and multiple metastasis over the right chest wall and right axillary. Therefore, cancer recurrence was suspected. Considering the rapid progression of the disease and reviewing past medical history, medical treatment procedures, and pathological report, the final diagnosis of inflammatory breast cancer (IBC) was made. After multimodal treatments, the tumors were eliminated. Given that IBC is easily confused with inflammatory diseases and other locally advanced breast cancer (LABC), if the breast is inflamed and antibiotic treatments are not effective for two weeks inflammatory breast cancer (IBC) must be included in the differential diagnosis. The healthcare provider must keep IBC’s characteristics in mind to avoid delay treatment which might en-danger the patient’s life.